Join us in celebrating and honoring the up-and-coming leaders who are vital to the future of the pharmaceutical and biotech industry.
In order to nominate yourself or someone you think is an Emerging Pharma Leader, first consider the qualities, knowledge, skills, and activities of the nominee. Are they headed for the C-Suite? Do they have what it takes to make the tough decisions that will continue to face manufacturers in the coming years? Can they navigate the commercial, financial, scientific, R&D, marketing, sales, and/or market access with leadership and inspiration? Do they have what it takes to get to the next level?
To review the accomplishments of 2020 winners, read here.
*The deadline for submissions is March 1, 2021*
If you have any questions on the entry process, please contact the organizers by email here.
For the official press release from MJH Life Sciences on the 2021 Emerging Pharma Leaders Awards, click here.
To sign up and submit a nomination, click here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
Elevating and De-Risking Your Drug Portfolio Strategy With AI
November 18th 2024Artificial intelligence (AI) can improve risk assessment and decision-making in drug development by applying objective, data-driven criteria consistently. Companies should focus on the quality of data, selecting the right AI use cases, and leveraging external partners to maximize the potential of AI.